KDM3B
protein-codinglysine demethylase 3B, the group of Lysine demethylases
Gene summary
Predicted to enable chromatin DNA binding activity; histone H3K9 demethylase activity; and transcription coregulator activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. Biomarker of acute lymphoblastic leukemia; breast cancer; colorectal cancer; and lung non-small cell carcinoma. [provided by Alliance of Genome Resources, Jul 2025]
- C5orf7
- JMJD1B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~84.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0030012
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0030012
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0030012
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: ClinGen
*KDM3B* encodes a histone demethylase involved in H3K9 demethylation, a critical process in chromatin modification required for transcriptional regulation. *KDM3B* was first reported in relation to autosomal dominant syndromic intellectual disability in 2019 (Diets et al., PMID: 30929739). The disorder is characterized by developmental delay, mild to moderate intellectual disability, and facial dysmorphisms. Additional phenotypic features include feeding difficulties in infancy, hypotonia, joint hypermobility, short stature, and behavior problems, including autism spectrum disorder and ADHD. Eighteen variants (missense, nonsense, frameshift, and splice site) that have been reported in 19 probands in 5 publications (PMIDs: 28135719, 30885698, 30929739, 36274669, 36757469) are included in this curation. Most variants occur *de novo*, but can also be inherited from similarly affected parents. The mechanism of pathogenicity is loss of function. This gene-disease relationship is also supported by experimental evidence, including biochemical function, protein interaction, and a mouse model (PMIDs: 22615488, 29276005, 34217333). Several other genes encoding lysine demethylases have been implicated in intellectual disability and autism. In summary, there is definitive evidence supporting the relationship between *KDM3B* and autosomal dominant syndromic intellectual disability. This has been repeatedly demonstrated in both research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on February 21, 2024 (SOP Version 10).
Inheritance Pattern: AD
Disease ID:MONDO:0030012
Submitter: Illumina
Inheritance Pattern: AD
Disease ID:MONDO:0030012
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic; Oncologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic; Oncologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Multiple patients were ascertained from a cohort of children with cancer, and a potential elevated risk of cancer may indicate that awareness may allow early diagnosis and management of oncologic sequelae
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KDM3B variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016604.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 44 | 2 | 55 | ||
| missense | 7 | 10 | 326 | 46 | 3 | 392 |
| nonsense | 10 | 6 | 1 | 17 | ||
| start loss | 0 | |||||
| frameshift | 6 | 6 | 1 | 13 | ||
| splice donor/acceptor (+/-2bp) | 4 | 8 | 12 | |||
| Total | 23 | 26 | 345 | 90 | 5 | 489 |
Highest pathogenic variant AF is 0.0000013706347
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057688.3 | 24 | MANE Select | |
| Ensembl | ENSP00000326563.5 | 24 | MANE Select | |
| Ensembl | ENSP00000423012.1 | 2 | Standard | |
| Ensembl | ENSP00000425186.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- HDMs demethylate histones
- Chromatin modifying enzymes
- Chromatin organization
Biological Process
- histone H3-K9 demethylation
- oxidation-reduction process
- response to cisplatin
- cellular oxidant detoxification
Molecular Function
- transcription regulatory region sequence-specific DNA binding
- antioxidant activity
- chromatin DNA binding
- histone demethylase activity
- histone demethylase activity (H3-K9 specific)
Cellular Component
- chromatin
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000314358
- Coding exons
- 24
- Length
- 84433
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125746
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.98 | 524 | 958 | 0.547 | 0.0000525 | 11457 |
| Missense (PolyPhen) | 86 | 301.08 | 0.28564 | 3608 | ||
| Synonymous | 0.245 | 361 | 367 | 0.984 | 0.0000204 | 3620 |
| Loss of Function | 8.17 | 1 | 79.7 | 0.0125 | 0.00000481 | 863 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000018 | 0.0000088 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone demethylase that specifically demethylates 'Lys- 9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May have tumor suppressor activity. {ECO:0000269|PubMed:16603237}.;
Recessive Scores
- pRec
- 0.0982
Intolerance Scores
- RVIS EVS
- -0.75
- RVIS percentile EVS
- 13.74
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.806
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |